 | | Vol. 11.27 – 13 July, 2022 |
| |
|
|
| Investigators demonstrated that lower expression of MAN1A1 in glioma stem cells resulted in the formation of high-mannose type N-glycan on CD133.
[Advanced Science] |
|  |
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Scientists reported that little characterized cysteine-rich protein 1 (CRIP1) was upregulated in hepatocellular carcinoma and associated with poor prognosis.
[EMBO Journal] |
|
|
|
| Investigators found that PFK158 treatment and PFKFB3 knockdown enhanced the ABCG2-interacting drugs doxorubicin, etoposide, and 5-fluorouracil in reducing cell viability under conditions of enriched CSCs.
[Oncogene] |
|
|
|
| Researchers built a 3D in vitro model system of bone marrow (BM) organoids that recapitulated several structural and cellular components of native BM.
[APL Bioengineering] |
|
|
|
| To determine the regulatory action of NOTCH1-cMYC signaling in CSC maintenance, scientists evaluated the effect of a selective NOTCH1 inhibitor, crenigacestat, on CSC capacities in anaplastic thyroid cancer.
[Thyroid] |
|
|
|
| The authors investigated the photothermal effect of gold nanorods on human neuroblastoma CD133+ CSCs via autophagic cell death.
[Scientific Reports] |
|
|
|
| Scientists prospectively collected circulating tumor cell data from patients with operable non-metastatic esophageal cancer from April 2009 to November 2016 enrolled in their QUINTETT esophageal cancer randomized trial.
[BMC Cancer] |
|
|
|
| The authors analyzed 29 stem cell collections of 19 adult patients at a median age of 27 years mobilized after vincristine, ifosfamide, doxorubicine, and etoposide, dactinomycin, and ifosfamide chemotherapy.
[Transfusion] |
|
|
|
| Scientists explored whether casticin suppressed stemness in cancer stem-like cells obtained from human cervical cancer and the underlying mechanism.
[Chinese Journal of Integrative Medicine] |
|
|
|
|
| The selective persistence of rare leukemic stem cells following therapy-induced remission implies unique resistance mechanisms of leukemic stem cells towards conventional therapeutic strategies and that leukemic stem cells represent the cellular origin of relapse.
[Journal of Internal Medicine] |
|
|
|
|
| The Medical Research Council, Cancer Research UK, and Wellcome have announced £1 billion of funding for the Francis Crick Institute helping secure the future of the UK as a scientific powerhouse.
[The Francis Crick Institute] |
|
|
|
|
| September 12 – 14, 2022
Liverpool, England, United Kingdom |
|
|
|
|
|
| | The Chinese University of Hong Kong – Hong Kong, China |
|
|
|
| | Albert Einstein College of Medicine – Bronx, New York, United States |
|
|
|
| | Universit̩ catholique de Louvain РBrussels, Belgium |
|
|
|
| | Fred Hutchinson Cancer Research Center – Seattle, Washington, United States |
|
|
|
| | Boehringer Ingelheim – Vienna, Austria |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
